Caffeic acid phenethyl ester inhibits oral cancer cell metastasis by regulating matrix metalloproteinase-2 and the mitogen-activated protein kinase pathway

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Peng, Chih Yu ^a,b   Yang, Hui Wen ^a,b   Chu, Yin Hung ^a   Chang, Yu Chao ^a,b   Hsieh, Ming Ju ^a   Chou, Ming Yung ^a,b   Yeh, Kun Tu ^c   Lin, Yueh Min ^c   Yang, Shun Fa ^a,b   Lin, Chiao Wen ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; FOCAL ADHESION KINASE; GELATIN; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL INVASION; CELL MIGRATION; ENZYME ACTIVITY; HUMAN; METASTASIS; MOLECULAR MECHANICS; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 84872137563     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/732578     Document Type: Article

References (43)

1. Spiro R. H., Alfonso A. E., Farr H. W., Strong E. W., Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging. American Journal of Surgery 1974 128 4 562 567 2-s2.0-0016267916
2. Stetler-Stevenson W. G., Liotta L. A., Kleiner D. E., Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB Journal 1993 7 15 1434 1441 2-s2.0-0027140406 (Pubitemid 24003262)
3. Chien M. H., Ying T. H., Hsieh Y. S., Chang Y. C., Yeh C. M., Ko J. L., Lee W. S., Chang J. H., Yang S. F., Dioscorea nipponica Makino inhibits migration and invasion of human oral cancer HSC-3 cells by transcriptional inhibition of matrix metalloproteinase-2 through modulation of CREB and AP-1 activity. Food and Chemical Toxicology 2012 50 558 566
4. Yang S. F., Chen M. K., Hsieh Y. S., Yang J. S., Zavras A. I., Hsieh Y. H., Su S. C., Kao T. Y., Chen P. N., Chu S. C., Antimetastatic effects of Terminalia catappa L. on oral cancer via a down-regulation of metastasis-associated proteases. Food and Chemical Toxicology 2010 48 4 1052 1058 2-s2.0-77549086838 10.1016/j.fct.2010.01.019
5. Egeblad M., Werb Z., New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer 2002 2 3 161 174 2-s2.0-0036512208 (Pubitemid 37328786)
6. Nelson A. R., Fingleton B., Rothenberg M. L., Matrisian L. M., Matrix metalloproteinases: biologic activity and clinical implications. Journal of Clinical Oncology 2000 18 5 1135 1149 2-s2.0-0033999308 (Pubitemid 30123793)
7. Björklund M., Koivunen E., Gelatinase-mediated migration and invasion of cancer cells. Biochimica et Biophysica Acta 2005 1755 1 37 69 2-s2.0-19344366798 10.1016/j.bbcan.2005.03.001 (Pubitemid 40720240)
8. Ranuncolo S. M., Armanasco E., Cresta C., De Kier Joffe E. B., Puricelli L., Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients. International Journal of Cancer 2003 106 5 745 751 2-s2.0-0042023384 10.1002/ijc.11288 (Pubitemid 36993399)
9. Yokoyama M., Ochi K., Ichimura M., Mizushima T., Shinji T., Koide N., Tsurumi T., Hasuoka H., Harada M., Matrix metalloproteinase-2 in pancreatic juice for diagnosis of pancreatic cancer. Pancreas 2002 24 4 344 347 2-s2.0-0036242211 10.1097/00006676-200205000-00004 (Pubitemid 34441914)
10. Sauer C. G., Kappeler A., Späth M., Kaden J. J., Michel M. S., Mayer D., Bleyl U., Grobholz R., Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients. Virchows Archiv 2004 444 6 518 526 2-s2.0-3042845832 (Pubitemid 38858375)
11. Bugdayci G., Kaplan T., Sezer S., Turhan T., Koca Y., Kocer B., Yildirim E., Matrix metalloproteinase-9 in broncho-alveolar lavage fluid of patients with non-small cell lung cancer. Experimental Oncology 2006 28 2 169 171 2-s2.0-33746536082 (Pubitemid 44140273)
12. Hong S. D., Hong S. P., Lee J. I., Lim C. Y., Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncology 2000 36 2 207 213 2-s2.0-0034162024 10.1016/S1368-8375(99)00088-3 (Pubitemid 30169164)
13. Coticchia C. M., Curatolo A. S., Zurakowski D., Yang J., Daniels K. E., Matulonis U. A., Moses M. A., Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels. Gynecologic Oncology 2011 123 295 300
14. Wong T. S., Kwong D. L. W., Sham J. S. T., Wei W. I., Kwong Y. L., Yuen A. P. W., Clinicopathologic significance of plasma matrix metalloproteinase-2 and -9 levels in patients with undifferentiated nasopharyngeal carcinoma. European Journal of Surgical Oncology 2004 30 5 560 564 2-s2.0-2542609029 10.1016/j.ejso.2004.02.007 (Pubitemid 38701881)
15. Song N., Sung H., Choi J. Y., Han S., Jeon S., Song M., Lee Y., Park C., Park S. K., Lee K. M., Yoo K. Y., Noh D. Y., Ahn S. H., Lee S. A., Kang D., Preoperative serum levels of matrix metalloproteinase-2 (MMP-2) and survival of breast cancer among Korean women. Cancer Epidemiology, Biomarkers & Prevention 2012 21 1371 1380
16. Dobrowolski J. W., Vohora S. B., Sharma K., Shah S. A., Naqvi S. A. H., Dandiya P. C., Antibacterial, antifungal, antiamoebic, antiinflammatory and antipyretic studies on propolis bee products. Journal of Ethnopharmacology 1991 35 1 77 82 2-s2.0-0026045838
17. Michaluart P., Masferrer J. L., Carothers A. M., Subbaramaiah K., Zweifel B. S., Koboldt C., Mestre J. R., Grunberger D., Sacks P. G., Tanabe T., Dannenberg A. J., Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Research 1999 59 10 2347 2352 2-s2.0-0033562995 (Pubitemid 29242281)
18. Mirzoeva O. K., Yaqoob P., Knox K. A., Calder P. C., Inhibition of ICE-family cysteine proteases rescues murine lymphocytes from lipoxygenase inhibitor-induced apoptosis. FEBS Letters 1996 396 2-3 266 270 2-s2.0-0030569290 10.1016/0014-5793(96)01111-8 (Pubitemid 26377837)
19. Lee Y., Shin D. H., Kim J. H., Hong S., Choi D., Kim Y. J., Kwak M. K., Jung Y., Caffeic acid phenethyl ester-mediated Nrf2 activation and I B kinase inhibition are involved in NF B inhibitory effect: structural analysis for NF B inhibition. European Journal of Pharmacology 2010 643 1 21 28 2-s2.0-77955050631 10.1016/j.ejphar.2010.06.016
20. Jung W. K., Lee D. Y., Choi Y. H., Yea S. S., Choi I., Park S. G., Seo S. K., Lee S. W., Lee C. M., Kim S. K., Jeon Y. J., Choi I. W., Caffeic acid phenethyl ester attenuates allergic airway inflammation and hyperresponsiveness in murine model of ovalbumin-induced asthma. Life Sciences 2008 82 13-14 797 805 2-s2.0-40649123732 10.1016/j.lfs.2008.01.014
21. Chuu C. P., Lin H. P., Ciaccio M. F., Kokontis J. M., Hause, Jr R. J., Hiipakka R. A., Liao S., Jones R. B., Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks. Cancer Prevention Research 2012 5 788 797
22. Lee Y. T., Don M. J., Hung P. S., Shen Y. C., Lo Y. S., Chang K. W., Chen C. F., Ho L. K., Cytotoxicity of phenolic acid phenethyl esters on oral cancer cells. Cancer Letters 2005 223 1 19 25 2-s2.0-18844433280 10.1016/j.canlet.2004. 09.048 (Pubitemid 40693707)
23. Watabe M., Hishikawa K., Takayanagi A., Shimizu N., Nakaki T., caffeic acid phenethyl ester induces apoptosis by inhibition of NFkappaB and activation of Fas in human breast cancer MCF-7 cells. Journal of Biological Chemistry 2004 279 7 6017 6026 2-s2.0-1242294398 10.1074/jbc.M306040200 (Pubitemid 38220634)
24. Ramqvist T., Dalianis T., Oropharyngeal cancer epidemic and human papillomavirus. Emerging Infectious Diseases 2010 16 11 1671 1677 2-s2.0-77958610293 10.3201/eid1611.100452
25. Coussens L. M., Werb Z., Matrix metalloproteinases and the development of cancer. Chemistry and Biology 1996 3 11 895 904 2-s2.0-0030293598 (Pubitemid 27017088)
26. Chien M. H., Lin C. W., Cheng C. W., Wen Y. C., Yang S. F., Matrix metalloproteinase (MMP)-2 as a target for head and neck cancer therapy. Expert Opinion on Therapeutic Targets. In press
27. Katayama A., Bandoh N., Kishibe K., Takahara M., Ogino T., Nonaka S., Harabuchi Y., Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis. Clinical Cancer Research 2004 10 2 634 640 2-s2.0-0842311599 10.1158/1078-0432.CCR-0864-02 (Pubitemid 38174003)
28. Kurahara S., Shinohara M., Ikebe T., Nakamura S., Beppu M., Hiraki A., Takeuchi H., Shirasuna K., Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head & Neck 1999 21 627 638 (Pubitemid 29459868)
29. Qin H., Sun Y., Benveniste E. N., The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. Journal of Biological Chemistry 1999 274 41 29130 29137 2-s2.0-0032857460 10.1074/jbc.274.41.29130 (Pubitemid 29477077)
30. Snoek-van Beurden P. A. M., Von Den Hoff J. W., Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. BioTechniques 2005 38 1 73 83 2-s2.0-12344258657 (Pubitemid 40139420)
31. Nuttall R. K., Pennington C. J., Taplin J., Wheal A., Yong V. W., Forsyth P. A., Edwards D. R., Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells. Molecular Cancer Research 2003 1 5 333 345 2-s2.0-0037359601 (Pubitemid 36437920)
32. Imren S., Kohn D. B., Shimada H., Blavier L., DeClerck Y. A., Overexpression of tissue inhibitor of metalloproteinases-2 by retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Research 1996 56 13 2891 2895 2-s2.0-0030012534
33. Valente P., Fassina G., Melchiori A., Masiello L., Cilli M., Vacca A., Onisto M., Santi L., Stetler-Stevenson W. G., Albini A., TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. International Journal of Cancer 1998 75 246 253 (Pubitemid 28100066)
34. Visscher D. W., Höyhtyä M., Ottosen S. K., Liang C. M., Sarkar F. H., Crissman J. D., Fridman R., Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. International Journal of Cancer 1994 59 3 339 344 2-s2.0-0028148301 10.1002/ijc.2910590308 (Pubitemid 24331823)
35. Chen P. N., Hsieh Y. S., Chiou H. L., Chu S. C., Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chemico-Biological Interactions 2005 156 2-3 141 150 2-s2.0-26044455880 10.1016/j.cbi.2005.08.005 (Pubitemid 41406237)
36. Hsieh Y. S., Chu S. C., Yang S. F., Chen P. N., Liu Y. C., Lu K. H., Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2. Carcinogenesis 2007 28 5 977 987 2-s2.0-34447094968 10.1093/carcin/bgl221 (Pubitemid 47072181)
37. Weng C. J., Chau C. F., Hsieh Y. S., Yang S. F., Yen G. C., Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF- B and AP-1. Carcinogenesis 2008 29 1 147 156 2-s2.0-38849178686 10.1093/carcin/bgm261 (Pubitemid 351201753)
38. Huang C., Jacobson K., Schaller M. D., MAP kinases and cell migration. Journal of Cell Science 2004 117 20 4619 4628 2-s2.0-7244231301 10.1242/jcs.01481 (Pubitemid 39433429)
39. Huang Z., Yan D. P., Ge B. X., JNK regulates cell migration through promotion of tyrosine phosphorylation of paxillin. Cellular Signalling 2008 20 11 2002 2012 2-s2.0-52149121370 10.1016/j.cellsig.2008.07.014
40. Fromigué O., Hamidouche Z., Marie P. J., Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. Journal of Biological Chemistry 2008 283 45 30549 30556 2-s2.0-57649217290 10.1074/jbc.M801436200
41. Zhong J., Gencay M. M. C., Bubendorf L., Burgess J. K., Parson H., Robinson B. W. S., Tamm M., Black J. L., Roth M., ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells. Journal of Cellular Physiology 2006 207 2 540 552 2-s2.0-33645657833 10.1002/jcp.20605
42. Kumar B., Koul S., Petersen J., Khandrika L., Hwa J. S., Meacham R. B., Wilson S., Koul H. K., p38 Mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity. Cancer Research 2010 70 2 832 841 2-s2.0-76549130383 10.1158/0008-5472.CAN-09- 2918
43. Tian T., Nan K. J., Guo H., Wang W. J., Ruan Z. P., Wang S. H., Liang X., Lu C. X., PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway. Oncology Reports 2010 23 6 1593 1600 2-s2.0-77951722798 10.3892/or-00000800